chartexchange

ZNTL
Zentalis Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
1.38USD-7.383%(-0.11)1,210,589
Pre-marketNov 18, 2026 8:17:30 AM EST
1.47USD-1.342%(-0.02)
After-hoursNov 18, 2026 4:00:30 PM EST
1.36USD-1.449%(-0.02)
Loading…
Loading…
134.62M
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$1.49
Beta
1.87
52-Week High
$6.95 2026-04-10
52-Week Low
$1.28 2025-11-21
SMA 50
$2.38
SMA 200
$3.38
Avg. Vol 10D
1.50M
Avg. Vol 30D
1.35M
Avg. Vol 90D
1.26M
Relative Vol
0.90
69.63M
0.3000%
2,100,000
380
Mar 25, 2027 (126d)
ZNTL Profile

developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer

ZNTL Performance
PeriodPriceDateChangeBeta
1W1.682026-11-12-18.45%1.322
1M2.302026-10-19-40.44%0.874
3M3.822026-08-19-64.14%1.414
6M3.542026-05-19-61.30%1.361
1Y1.332025-11-19+3.01%1.871
2Y2.992024-11-19-54.18%—
5Y77.632021-11-19-98.23%1.709
ZNTL Stock Summary

Zentalis Pharmaceuticals, Inc. Common Stock (NASDAQ:ZNTL) stock price today is $1.37, and today's volume is 1,210,589. ZNTL is down 8.054% today. The 30 day average volume is 1.35M. ZNTL market cap is $134.62M with 98.27M shares outstanding.